Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bulk RNA-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

ABSTRACT: Bulk RNA-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

PROVIDER: PRJEB63259 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR11572020.fastq.gz	Fastqsanger.gz
	ERR11572021.fastq.gz	Fastqsanger.gz
	ERR11572022.fastq.gz	Fastqsanger.gz
	ERR11572023.fastq.gz	Fastqsanger.gz
	ERR11572024.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Bulk RNA-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:We performed bulk RNA sequencing on sorted T cells (7AAD- Calcein blue+ CD45+ THY1.1- TCRb+) in an orthotopic EMT6 tumor model 7 days after treatment initiation in four experimental groups: 1) Control 2) aPD-L1 3) aTGFb 4) aPD-L1 and aTGFb.

2023-06-30 | E-MTAB-13079 | biostudies-arrayexpress

ScRNA/TCR-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:We performed 10x single cell RNA and VDJ sequencing on sorted T cells (7AAD- Calcein blue+ CD45+ THY1.1- TCRb+) in an orthotopic EMT6 tumor model 7 days after treatment initiation in four experimental groups: 1) Control 2) aPD-L1 3) aTGFb 4) aPD-L1 and aTGFb.

2023-06-30 | E-MTAB-13073 | biostudies-arrayexpress

scRNA-seq of stromal, tumor and immune cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:We performed 10x single cell RNA-seq on sorted populations: T cell (7AAD- Calcein blue+ CD45+ THY1.1- TCRb+), fibroblasts (7AAD- Calcein Blue+ CD45- THY1.1- CD31- PDPN+), myeloid cells (7AAD- Calcein Blue+ CD45+ THY1.1- CD11b+) and tumor cells (7AAD- Calcein Blue+ CD45- THY1.1+) from cells in an orthotopic EMT6 tumor model 7 days after treatment initiation in four experimental groups: 1) Control 2) aPD-L1 3) aTGFb 4) aPD-L1 and aTGFb.

2023-06-30 | E-MTAB-13072 | biostudies-arrayexpress

ScRNA/TCR-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:ScRNA/TCR-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

| PRJEB63367 | ENA

scRNA-seq of stromal, tumor and immune cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:scRNA-seq of stromal, tumor and immune cells from EMT6 tumors treated with aTGFb/aPD-L1

| PRJEB63228 | ENA

Gene expression changes in mouse breast tumor tissue (EMT6) after anti-PD-L1 resistance

Project description:RNA sequencing analysis was used to identify changes in mouse breast tumor tissues (EMT6) resistant to anti-PD-L1 (PDR).

2024-10-14 | GSE186032 | GEO

Gene expression changes in mouse breast cancer cells (EMT6) after anti-PD-L1 treatment

Project description:RNA sequencing analysis was used to identify changes in mouse breast cancer (EMT6) following prolonged anti-PD-L1 in vitro (PDRvitro).

2024-10-14 | GSE186034 | GEO

Extracellular matrix-myCAF signatures correlate with resistance to neoadjuvant aPD-L1 immune checkpoint inhibition with durvalumab + metformin in HPV+ HNSCC

Project description:In HPV-positive head and neck squamous cell carcinoma (HNSCC), early resistance to neoadjuvant durvalumab plus metformin therapy is associated with baseline enrichment of extracellular matrix–associated myofibroblastic cancer-associated fibroblasts (ECM-myCAF) within the tumor compartment. In contrast, treatment responders exhibit a distinct tumor microenvironment marked by baseline enrichment of Langerhans-like dendritic cells and post-treatment upregulation of antigen presentation pathways. These findings highlight the tumor-stroma interface as a key determinant of immunotherapy response and provide a foundation for biomarker-driven patient selection. Identifying stromal and immune signatures predictive of response to neoadjuvant aPD-L1 therapy supports future strategies targeting the tumor microenvironment to improve outcomes in HNSCC.

2025-08-29 | GSE306800 | GEO

Somatic L1 Retrotransposition of Colorectal Tumors

Project description:Somatic L1 Retrotransposition of Colorectal Tumors

| PRJNA173389 | ENA

EMT6 3D CS-E

Project description:Mouse EMT6 breast cancer cells were grown in 3D Matrigel culture. Effects of the glycosaminoglycan chondroitin sulfate-E (CS-E) versus untreated controls on transcriptional programs was investigated.

2014-08-01 | E-MTAB-2645 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data